MWNA
ULBI icon

Marshall Wace North America’s Ultralife ULBI Stock Holding History

Marshall Wace North America’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,500
Closed -$36K – 1624
2019
Q1 		$36K Buy
+3,500
New +$31.4K ﹤0.01% 1316

Other funds holding ULBI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace North America's ULBI Position: Q2 2019 in Review

Marshall Wace North America sold out of Ultralife (ULBI) in Q2 2019, closing a stake of 3,500 shares — an estimated $36K sold.

Marshall Wace North America first reported a position in ULBI in Q1 2019 and held it in 1 quarter. The position peaked at $36K in Q1 2019. 35 funds tracked by Wall St. Rank hold ULBI as of Q2 2019.

  • Marshall Wace North America reported no remaining Ultralife position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace North America sold 3,500 Ultralife shares in Q2 2019, an estimated $36K.
  • Marshall Wace North America first reported a position in Ultralife in Q1 2019 and held it in 1 quarter.
  • Marshall Wace North America's Ultralife position peaked at $36K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Ultralife as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.